CVS Health Corporation
CVS
$78.66
$0.110.14%
NYSE
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Net Income | 469.00M | 4.53B | 5.28B | 4.61B | 5.02B |
| Total Depreciation and Amortization | 4.61B | 4.63B | 4.61B | 4.60B | 4.58B |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 4.88B | 59.00M | 52.00M | -213.00M | 552.00M |
| Change in Net Operating Assets | -847.00M | -1.66B | -1.19B | 109.00M | -5.54B |
| Cash from Operations | 9.11B | 7.57B | 8.76B | 9.11B | 4.61B |
| Capital Expenditure | -2.82B | -2.79B | -2.82B | -2.78B | -2.92B |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -439.00M | -161.00M | -90.00M | -95.00M | -205.00M |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -1.17B | -2.73B | -3.37B | -4.74B | -5.18B |
| Cash from Investing | -4.42B | -5.68B | -6.28B | -7.61B | -8.31B |
| Total Debt Issued | 8.24B | 5.79B | 7.31B | 9.83B | 5.76B |
| Total Debt Repaid | -7.55B | -5.30B | -6.36B | -4.77B | -2.14B |
| Issuance of Common Stock | 327.00M | 324.00M | 302.00M | 361.00M | 377.00M |
| Repurchase of Common Stock | -149.00M | -133.00M | -161.00M | -3.21B | -3.21B |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -3.39B | -3.38B | -3.37B | -3.37B | -3.31B |
| Other Financing Activities | 41.00M | 11.00M | 36.00M | 26.00M | -13.00M |
| Cash from Financing | -2.48B | -2.68B | -2.24B | -1.14B | -2.54B |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 2.21B | -795.00M | 239.00M | 359.00M | -6.24B |